Eton Pharmaceuticals, Inc. (ETON) has 39 open-market insider trades by 11 insiders since 2018. Over the last six months insiders net sold $25.4M. The most active filer is Opaleye Management Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | — | 15 | $21.1M | 2026-07-14 |
| Sean Brynjelsen | CEOPres | — | 9 | $15.0M | 2026-08-20 |
| Harrow Health, Inc. | 10% Owner | — | 1 | $10.6M | 2021-04-12 |
| David Krempa | — | — | 4 | $6.0M | 2026-10-06 |
| Paul V. Maier | Dir | — | 2 | $3.0M | 2026-08-28 |
| Jennifer McKie Adams | Dir | — | 1 | $1.6M | 2026-06-17 |
| James R. Gruber | CFO | — | 1 | $1.3M | 2026-01-14 |
| Mark L. Baum | Dir | — | 1 | $60K | 2018-11-15 |
| William Wilson Troutman | CFOSecretary | — | 2 | $52K | 2021-08-20 |
| Charles J. Casamento | Dir | — | 2 | $51K | 2019-08-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Krempa | — | Sell | $229K | 2026-10-06 |
| Paul V. Maier | Director | Sell | $3.0M | 2026-08-28 |
| David Krempa | — | Sell | $1.6M | 2026-08-24 |
| Sean Brynjelsen | CEO & President | Sell | $6.1M | 2026-08-19 |
| Opaleye Management Inc. | 10% Owner | Sell | $1.1M | 2026-07-14 |
| Opaleye Management Inc. | 10% Owner | Sell | $4.8M | 2026-07-02 |
Companies that share insiders with ETON, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jennifer McKie Adams | Director | Sell | $1.6M | 2026-06-17 |
| Sean Brynjelsen | CEO & President | Sell | $3.8M | 2026-05-28 |
| David Krempa | — | Sell | $3.2M | 2026-05-22 |
| James R. Gruber | CFO | Sell | $1.3M | 2025-08-19 |
| David Krempa | — | Sell | $908K | 2025-06-12 |
| Opaleye Management Inc. | 10% Owner | Buy | $125K | 2025-06-10 |
| Sean Brynjelsen | CEO & President | Sell | $4.8M | 2025-06-03 |
| Opaleye Management Inc. | 10% Owner | Buy | $80K | 2024-10-23 |
| Opaleye Management Inc. | 10% Owner | Buy | $434K | 2024-10-04 |